Covered recipient · General Payments record
MEGAN S BROWN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$2,376.58
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,047.35 | 48 |
| Education | $514.30 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $247.87 | 6 |
| Stemline Therapeutics Inc. | $150.48 | 4 |
| Merck Sharp & Dohme Corporation | $144.92 | 7 |
| Incyte Corporation | $123.40 | 2 |
| SEAGEN INC. | $99.99 | 1 |
| Daiichi Sankyo Inc. | $93.47 | 2 |
| AVEO Pharmaceuticals, Inc. | $74.99 | 1 |
| Legend Biotech USA Inc. | $71.67 | 1 |
| Genentech USA, Inc. | $63.99 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $53.73 | 3 |
| EISAI INC. | $44.73 | 2 |
| Tempus AI, Inc | $44.45 | 2 |
| Lilly USA, LLC | $35.71 | 2 |
| Gilead Sciences, Inc. | $32.76 | 2 |
| GlaxoSmithKline, LLC. | $31.64 | 1 |
| Janssen Biotech, Inc. | $30.19 | 2 |
| Alexion Pharmaceuticals, Inc. | $28.00 | 2 |
| Amgen Inc. | $26.55 | 2 |
| ARRAY BIOPHARMA INC | $23.61 | 2 |
| PharmaEssentia USA Corporation | $19.86 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.93 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.61 | 1 |
| Mirati Therapeutics, Inc. | $17.58 | 1 |
| Astellas Pharma US Inc | $17.57 | 1 |
| Acerta Pharma LLC | $17.25 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.98 | 1 |
| ABBVIE INC. | $15.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.